Hannah Brendan - Insider Non-Derivative Transactions at Quince Therapeutics, Inc. (QNCX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 21, 2024, Hannah Brendan's relationship to Quince Therapeutics, Inc. (QNCX) is Officer (CHIEF BUSINESS OFFICER AND COO), and currently has 296,540 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other QNCX insiders.
Data Source: SEC.
Hannah Brendan - Insider Non-Derivative Transactions of QNCX Common Stock
Hannah Brendan - Insider Non-Derivative Transactions at QNCX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 22, 2024 | P -- (Common Stock) | 2280 | 0.61 | 267975 |
| Aug 22, 2024 | P -- (Common Stock) | 5000 | 0.62 | 272975 |
| Aug 22, 2024 | P -- (Common Stock) | 23565 | 0.63 | 296540 |
| Aug 21, 2024 | P -- (Common Stock) | 2500 | 0.61 | 262271 |
| Aug 21, 2024 | P -- (Common Stock) | 3424 | 0.6 | 265695 |
| Aug 20, 2024 | P -- (Common Stock) | 2155 | 0.58 | 259771 |
| Jun 5, 2024 | M -- (Common Stock) | 56061 | 0.55 | 257616 |
| Aug 9, 2023 | P -- (Common Stock) | 71762 | 1.22 | 201555 |